Celldex Therapeutics, Inc. Earnings Per Share (Diluted)
Celldex Therapeutics, Inc. (CLDX) reported Earnings Per Share (Diluted) of -$0.94 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-06
- Celldex Therapeutics, Inc. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.94.
- Celldex Therapeutics, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was -$1.18.
- Celldex Therapeutics, Inc. earnings per share, diluted for the quarter ending 2025-12-31 was -$0.31.
- Celldex Therapeutics, Inc. earnings per share, diluted for the quarter ending 2025-09-30 was -$1.01.
- Celldex Therapeutics, Inc. earnings per share, diluted for fiscal 2025 was -$3.90.
- Celldex Therapeutics, Inc. earnings per share, diluted for fiscal 2024 was -$2.45.
- Celldex Therapeutics, Inc. earnings per share, diluted for fiscal 2023 was -$2.92.
- Celldex Therapeutics, Inc. earnings per share, diluted for fiscal 2022 was -$2.40.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.94 10-Q · filed 2026-08-06 | -$2.11 10-Q · filed 2026-08-06 | -$1.71 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.93 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2026-03-31 | -$1.18 10-Q · filed 2026-05-07 | -$0.96 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.05 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.85 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-12-31 | -$0.31 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$1.12 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$1.85 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$3.90 10-K · filed 2026-02-25 |
| 2025-09-30 | -$1.01 10-Q · filed 2025-11-10 | -$3.72 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.67 10-Q · filed 2025-11-10 | -$2.30 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-06-30 | -$0.85 10-Q · filed 2026-08-06 | -$1.66 10-Q · filed 2026-08-06 | -$1.21 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.05 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-03-31 | -$0.81 10-Q · filed 2026-05-07 | -$0.62 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.32 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.21 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2024-12-31 | -$0.18 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.69 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$1.46 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$2.45 10-K · filed 2026-02-25 |
| 2024-09-30 | -$0.64 10-Q · filed 2025-11-10 | -$1178.46 derived: net income ÷ weighted average shares · filed 2025-11-10 | -$1.74 10-Q · filed 2025-11-10 | |
| 2024-06-30 | -$0.54 10-Q · filed 2025-08-07 | -$1.10 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | -$0.56 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$2.92 10-K · filed 2026-02-25 | |||
| 2023-09-30 | -$0.81 10-Q · filed 2024-11-06 | -$2.08 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | -$0.65 10-Q · filed 2024-08-08 | -$1.27 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | -$0.62 10-Q · filed 2024-05-06 | |||
| 2022-12-31 | -$2.40 10-K · filed 2025-02-27 | |||
| 2022-09-30 | -$0.57 10-Q · filed 2023-11-02 | -$1.83 10-Q · filed 2023-11-02 | ||
| 2022-06-30 | -$0.77 10-Q · filed 2023-08-08 | -$1.26 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | -$0.49 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | -$1.64 10-K · filed 2024-02-26 | |||
| 2021-09-30 | -$0.45 10-Q · filed 2022-11-09 | -$1.21 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | -$0.34 10-Q · filed 2022-08-08 | -$0.76 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | -$0.42 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | -$2.02 10-K · filed 2023-02-28 | |||
| 2019-12-31 | -$3.51 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |